Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Et register for mennesker med lungekræft

23. september 2026 opdateret af: Memorial Sloan Kettering Cancer Center

Pulmonal Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108

Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Observationel

Tilmelding (Anslået)

600

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

  • Navn: Bernard Park, MD
  • Telefonnummer: 646-888-3346
  • E-mail: parkb@mskcc.org

Studiesteder

    • Ontario
      • Toronto, Ontario, Canada, M5G 2C4
        • Rekruttering
        • University Health Network (Data Collection Only)
        • Kontakt:
    • Quebec
      • Montreal, Quebec, Canada, H2L 4M1
        • Rekruttering
        • Centre Hospitalier de l'Université de Montreal (Data Collection Only)
        • Kontakt:
          • Moishe Liberman, MD. PhD
          • Telefonnummer: 514-890-8000, ext: 26832
    • Arizona
      • Tucson, Arizona, Forenede Stater, 85704
        • Rekruttering
        • University of Arizona (Data Collection Only)
        • Kontakt:
    • California
      • San Diego, California, Forenede Stater, 92103
        • Rekruttering
        • University of California San Diego (Data collection)
        • Kontakt:
          • Joshua Boys, MD
          • Telefonnummer: 858-657-7777
    • Illinois
      • Chicago, Illinois, Forenede Stater, 606012
        • Rekruttering
        • Rush University Medical Center (Data collection only)
        • Kontakt:
          • Christopher Seder, MD
          • Telefonnummer: 312-738-3732
      • Evanston, Illinois, Forenede Stater, 60201
        • Rekruttering
        • Endeavor Health
        • Kontakt:
          • Seth Krantz, MD
          • Telefonnummer: 847-570-2868
    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02114
        • Rekruttering
        • Massachusetts General Hospital Cancer Center (Data Collection Only)
        • Kontakt:
          • Michael Lanuti, MD
          • Telefonnummer: 617-726-6751
      • Boston, Massachusetts, Forenede Stater, 02115
        • Rekruttering
        • Brigham and Women's Hospital (Data Collection Only)
        • Kontakt:
          • Paula A Ugalde Figueroa, MD
          • Telefonnummer: 617-525-7532
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48109
        • Rekruttering
        • University of Michigan (Data Collection Only)
        • Kontakt:
          • Jules Lin, MD
          • Telefonnummer: 734-936-8857
    • New Jersey
      • Basking Ridge, New Jersey, Forenede Stater, 07920
        • Rekruttering
        • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
      • Middletown, New Jersey, Forenede Stater, 07748
        • Rekruttering
        • Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
      • Montvale, New Jersey, Forenede Stater, 07645
        • Rekruttering
        • Memorial Sloan Kettering Bergen (Limited Protocol Activities)
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
    • New York
      • Commack, New York, Forenede Stater, 11725
        • Rekruttering
        • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
      • Harrison, New York, Forenede Stater, 10604
        • Rekruttering
        • Memorial Sloan Kettering Westchester (Limited Protocol Activities)
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
      • New York, New York, Forenede Stater, 10065
        • Rekruttering
        • Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        • Kontakt:
          • Yuan Liu, MD, PhD
          • Telefonnummer: 646-888-3640
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
        • Ledende efterforsker:
          • David Jones, PhD
      • Uniondale, New York, Forenede Stater, 11553
        • Rekruttering
        • Memorial Sloan Kettering Nassau (Limited Protocol Activities)
        • Kontakt:
          • David Jones, MD
          • Telefonnummer: 212-639-6428
    • Pennsylvania
      • Philadelphia, Pennsylvania, Forenede Stater, 19107
        • Rekruttering
        • Thomas Jefferson University Hospital (Data Collection Only)
        • Kontakt:
      • Pittsburgh, Pennsylvania, Forenede Stater, 15212
        • Rekruttering
        • ALLEGHENY HEALTH NETWORK (Data Collection Only)
        • Kontakt:
          • Benny Weksler, MD
          • Telefonnummer: 412-359-6137
    • Texas
      • Dallas, Texas, Forenede Stater, 75246
        • Rekruttering
        • Baylor University Medical Center (Data Collection Only)
        • Kontakt:
      • Houston, Texas, Forenede Stater, 77030
        • Rekruttering
        • MD Anderson Cancer Center (Data Collection Only)
        • Kontakt:
          • David Rice, MD
          • Telefonnummer: 800-392-1611

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

All study subjects will be recruited from their respective clinics (i.e., Thoracic Surgery, Pulmonary, Survivorship, etc.) at participating sites. Potential research subjects will be identified by a member of the patient's treatment team, the protocol investigator, or research team by screening patients' medical records. If eligible, the study will be discussed with each patient.

Beskrivelse

Inclusion Criteria:

  • Age ≥18 years
  • Patients suitable for segmentectomy, according to the treating surgeon
  • Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology

Exclusion Criteria:

  • Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years

  • History of chemotherapy or radiation therapy for a previous lung cancer

  • Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery

  • Carcinoid tumors

  • History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix

  • Actively receiving treatment for other malignancies

  • Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis.

    • Multi-segmental resection from the same lobe is not a criterion for exclusion.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Participants with Lung Cancer

Participants undergoing planned pulmonary segmentectomy for primary lung cancer

Participants-reported outcomes will be collected using the Patient-Reported Outcomes Measurement Information System (PROMIS). PROMIS is a web-based platform developed by the National Institutes of Health. Scoring is standardized on a scale from 0 to 100, with a population mean of 50 and standard deviation of 10 units. High scores mean more of the concept being measured. This study will use PROMIS surveys assessing three domains: physical function (PROMIS bank version 2.0), pain interference (PROMIS bank version 1.1), and dyspnea severity (PROMIS bank version 1.0)

Andre navne:
  • LØFTE

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Determine 3-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
Tidsramme: 3 years

DFS is measured from the date of surgery to the date of recurrence or death

3 years
Determine 5-year disease-free survival/DFS among patients undergoing pulmonary segmentectomy for lung cancer.
Tidsramme: 5 years

DFS is measured from the date of surgery to the date of recurrence or death

5 years

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: David Jones, MD, Memorial Sloan Kettering Cancer Center

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

15. maj 2024

Primær færdiggørelse (Anslået)

15. maj 2029

Studieafslutning (Anslået)

15. maj 2029

Datoer for studieregistrering

Først indsendt

16. maj 2024

Først indsendt, der opfyldte QC-kriterier

16. maj 2024

Først opslået (Faktiske)

22. maj 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

24. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

23. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 24-127

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .